Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 228
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02399306 | Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma | ||
| NCT03489616 | Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients | ||
| NCT03423849 | The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy | ||
| NCT00815308 | Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma | ||
| NCT04555226 | The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) | ||
| NCT07187752 | Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes | ||
| NCT03116984 | A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC | ||
| NCT04963595 | Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer | ||
| NCT04609540 | Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC | ||
| NCT06980259 | Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma | ||
| NCT06483919 | The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer | ||
| NCT07137052 | Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar | ||
| NCT05099848 | A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma | ||
| NCT06370663 | First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC | ||
| NCT03660761 | Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors | ||
| NCT05351346 | Genotype-guided Treatment in DLBCL | ||
| NCT05788029 | Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas | ||
| NCT06816771 | Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents | ||
| NCT03541278 | Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique | ||
| NCT03688035 | Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients | ||
| NCT02721563 | A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC | ||
| NCT04302415 | Metabolomics Explores Biomarkers for Metastatic Breast Cancer | ||
| NCT06312982 | A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer | ||
| NCT03837782 | Outcome of Resection for Colorectal Cancer | ||
| NCT02845882 | LBL-2016 for Children or Adolescents in China | ||
| NCT05044871 | Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer | ||
| NCT01317953 | Oral Green Tea Extract for Small Cell Lung Cancer | ||
| NCT03557411 | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC | ||
| NCT02958033 | Shandong Cancer Hospital Affiliated to Shandong University | ||
| NCT02577393 | Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy | ||
| NCT05934864 | Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST) | ||
| NCT06844422 | Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) | ||
| NCT07162519 | Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients | ||
| NCT07240753 | A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma | ||
| NCT05933967 | A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma | ||
| NCT07000643 | Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma | ||
| NCT04095390 | A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer | ||
| NCT04004975 | Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib | ||
| NCT02790190 | Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT07026422 | Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT) | ||
| NCT01642511 | Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative | ||
| NCT04246502 | Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer | ||
| NCT07261059 | AI-assisted Integrated Care to Promote Colonoscopy Uptake | ||
| NCT06778382 | Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer. | ||
| NCT03672136 | Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients | ||
| NCT06241807 | Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC | ||
| NCT06561308 | Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer | ||
| NCT03349177 | Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy | ||
| NCT06288373 | Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC | ||
| NCT01917578 | Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction |
